Trending Now
Selector Biosciences Inc. (NASDAQ:SELB) And Sarepta Therapeutics Inc. (NASDAQ:SRPT) Sign Research...
Selector Biosciences Inc. (NASDAQ:SELB) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) have announced the signing of a Research Option and License Agreement. The agreement grants Sarepta...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Finding the Last Squeeze-able Stocks in the Commodity Space (BTU, CEI,...
The commodity space is the clear winner in 2021. This is especially true if you count Bitcoin as a commodity. But even...
MAKE IT MODERN
LATEST REVIEWS
Exicure Inc. (NASDAQ: XCUR) Provides AN Update On Cavrotolimod...
Exicure Inc. (NASDAQ: XCUR) has provided an update regarding the Phase 1b/2 (AST-008) cavrotolimod study. The company is evaluating AST-008 in combination with LIBTAYO...
MAKE IT MODERN
PERFORMANCE TRAINING
Corona-virus related IPO’s that Wall Street is eyeing (ATC, CLHN, IMRA, AYLA, LYRA, ZNTL,...
With the madness in the market yesterday and overnight last night, recent volatility and the current state of the market will impact...
Kadmon Holdings Inc. (NASDAQ: KDMN) Announces Q2 2021 Results And REZUROCK Updates in cGVHD...
Kadmon Holdings Inc. (NASDAQ: KDMN) has reported its Q2 2021 financial results and offered operational updates.
REZUROCK approved for cGVHD
The company announced that the US...
Equilibrium Inc. (NASDAQ:EQ) Receives Positive Feedback From the FDA On Itolizimab Treating Hospitalized COVID-19...
Equillum Inc. (NASDAQ:EQ) has announced the completion of an FDA pre-investigational New Drug (IND) meeting under the Coronavirus Treatment Acceleration Program (CTAP).
Positive FDA feedback...
Adverum Biotechnologies Inc. (NASDAQ: ADVM) Receives Orphan Drug Designation For ADVM-062
Adverum Biotechnologies Inc. (NASDAQ: ADVM) has announced that the US FDA has granted ADVM-062 Orphan Drug Designation. ADVM-062 is a proprietary gene therapy candidate...
Agenus Inc (NASDAQ: AGEN) Inks Licensing Deal With Bristol-Myers Squibb Co (NYSE: BMY) To...
Agenus Inc (NASDAQ: AGEN) has partnered with Bristol-Myers Squibb Co (NYSE: BMY). As part of the agreement, Bristol Myers Squibb Co will study an...
MAKE IT MODERN
